» Articles » PMID: 15256215

The Pathways and Molecular Mechanisms Regulating Nrf2 Activation in Response to Chemical Stress

Overview
Date 2004 Jul 17
PMID 15256215
Citations 144
Authors
Affiliations
Soon will be listed here.
Abstract

The induction of many antioxidant and phase II drug-metabolizing enzymes by phenolic antioxidants and electrophilic compounds is regulated at the transcriptional level. The response to these compounds is mediated by the cis-acting antioxidant response element (ARE) found in the promoter of the encoding genes. The transcription factor NF-E2-related factor 2, or Nrf2, has emerged as the central protein that binds to the ARE to activate gene transcription. Data from many studies indicate that Nrf2 is constitutively and ubiquitously expressed in a number of tissues and cell lines and is thus responsible for the low-level expression of its target genes observed under physiological conditions. However, in cells exposed to oxidative stress, Nrf2 activity is increased, further driving the transcriptional activation of genes whose expression is essential to control cellular redox homeostasis. Recent studies suggest that the activation of Nrf2 involves a coordinated process and is regulated at multiple levels. Nrf2 activity is believed to be repressed through the binding of the cytoskeleton-associated protein Keap1, and its activation involves mechanisms that interfere with this interaction. Activation of Nrf2 has also been demonstrated to be dependent on mechanisms that mediate its stabilization. In this review, the mechanisms controlling this activation process as reported in recent studies will be examined and discussed, with particular emphasis on those affecting Nrf2 stability at the molecular level.

Citing Articles

Neuroprotective effects of L-carnitine towards oxidative stress and inflammatory processes: a review of its importance as a therapeutic drug in some disorders.

Guerreiro G, Deon M, Becker G, Dos Reis B, Wajner M, Vargas C Metab Brain Dis. 2025; 40(2):127.

PMID: 39954226 DOI: 10.1007/s11011-025-01545-6.


Remimazolam Suppresses Oxidative Stress and Apoptosis in Cerebral Ischemia/Reperfusion Injury by Regulating AKT/GSK-3β/NRF2 Pathway.

Duan M, Yu N, Liu J, Zhao Y, Zhang J, Song S Drug Des Devel Ther. 2025; 19():111-128.

PMID: 39807342 PMC: 11725640. DOI: 10.2147/DDDT.S478692.


Therapy-induced senescence in breast cancer: an overview.

Chembukavu S, Lindsay A Explor Target Antitumor Ther. 2024; 5(4):902-920.

PMID: 39280248 PMC: 11390292. DOI: 10.37349/etat.2024.00254.


Ethnic Differences, Lung Cancer Risk, and Association of NRF2 Gene Polymorphism with Gemcitabine-Based Chemotherapy.

Devika T, Mahalakshmi G, Mythili K, Srinivasa Rao K, Srinivasamurthy S, Biswajit D Cureus. 2024; 16(7):e64849.

PMID: 39026573 PMC: 11257374. DOI: 10.7759/cureus.64849.


Bilirubin ameliorates osteoarthritis via activating Nrf2/HO-1 pathway and suppressing NF-κB signalling.

Zhao X, Duan B, Wu J, Huang L, Dai S, Ding J J Cell Mol Med. 2024; 28(7):e18173.

PMID: 38494841 PMC: 10945086. DOI: 10.1111/jcmm.18173.